TG THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
TG THERAPEUTICS, INC. (TGTX) had Stock Issued During Period, Shares, New Issues of 5.43 million shares as of 2019-12-22, per its 10-K filed 2020-03-02.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2022-03-01
- 2019-12-22: Stock Issued During Period, Shares, New Issues 5.43M shares.
- 2019-03-01: Stock Issued During Period, Shares, New Issues 4.10M shares.
- 2017-03-31: Stock Issued During Period, Shares, New Issues 1 month 769.23K shares.
- 2017-03-09: Stock Issued During Period, Shares, New Issues 0 month 5.13M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|---|
| 2019-12-22 | 5.43M shares 10-K · filed 2020-03-02 | ||
| 2019-03-01 | 4.10M shares 10-K · filed 2022-03-01 | ||
| 2017-03-31 | 769.23K shares 10-K · filed 2020-03-02 | ||
| 2017-03-09 | 5.13M shares 10-Q · filed 2017-11-09 | ||
| 2014-03-11 | 2.70M shares 10-Q · filed 2014-05-14 | ||
| 2013-07-18 | 5.70M shares 10-K · filed 2015-03-16 | ||
| 2012-02-24 | 695.43K shares 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |